About Bill Gates
Bill Gates, co-chair of the Gates Foundation, faced renewed scrutiny in February 2026 following the release of Justice Department documents related to Jeffrey Epstein. The documents included draft emails, apparently written by Epstein to himself, containing graphic and unverified allegations about Gates. Gates denied the claims in interviews, stating that he only attended dinners with Epstein, never went to Epstein's island, and never met any women through him. He said he regretted every minute spent with Epstein and apologized for the association. His ex-wife, Melinda French Gates, said in response to the documents that questions about the allegations were for her ex-husband to answer, not her.
At the World Economic Forum in Davos in January 2026, Gates focused on global health and artificial intelligence. He announced a $50 million partnership between the Gates Foundation and OpenAI called "Horizon 1000," which aims to deploy AI tools in 1,000 primary healthcare clinics in Africa, starting in Rwanda. Gates described the initiative as a way to improve healthcare quality and efficiency by using AI to reduce paperwork and help patients communicate in their local languages. He also warned that global health funding cuts had led to an increase in childhood deaths for the first time in 25 years, with 4.8 million children under five dying in 2025 compared to 4.6 million the year before. Gates said the U.S. aid cuts were "abrupt and cruel" and expressed hope that funding would be restored.
Source: AI-verified profile updated from Bill Gates's recent appearances.
Browse all interviews →
✨ AI-enhanced transcript with speaker attribution
B
Bill Gates0:00
The world is on the brink of a great scientific achievement. A COVID-19 vaccine will likely be ready by early next year, in fact we'll probably have more than one vaccine ready. These vaccines will allow us to save millions of lives. They'll also have another enormous benefit: they'll allow us to develop a plan for the world to globally eliminate COVID-19. To achieve this goal of global elimination we need three things: the capacity to produce billions of vaccines, the funding to pay for them, and the systems to deliver them everywhere. The world's low and lower middle income countries are home to nearly half of the global population. Because they don't have the purchasing power of the wealthy countries, they risk not getting nearly enough doses unless we do better. They'll only be able to cover 14 percent of their people with a COVID-19 vaccine. A vaccine can make COVID-19 a preventable disease, and no one should die of a preventable disease simply because the country they live in can't afford the vaccine. But you don't even have to care about the equity view to see the problem with the rich country only scenario. Today, even wealthy countries with very low case numbers are still suffering. Australia and New Zealand have done a great job and gone long stretches with very few cases inside their borders, but their economies remain distorted because their trading partners are on lockdown, and occasionally a carrier of the virus comes into these countries creating new clusters of the disease. The only way to eliminate the threat of this disease somewhere is to eliminate it everywhere. The solution is not shaming the rich countries that are doing the natural thing of wanting to protect their people. The solution is to vastly increase the manufacturing capacity so we can cover everyone as soon as possible. It's been amazing to see these private companies agreeing to expand drug making capacity by using each other's factories. We have a number of agreements like this, but we need even more, especially for the vaccine. That's why I'm thrilled today to announce a new joint agreement signed this morning by 16 pharmaceutical companies and the Gates Foundation. In this agreement, the companies commit to, among other things, scaling up manufacturing at an unprecedented speed and making sure that approved vaccines reach broad distribution as early as possible. The next component we need for global elimination is the funding to pay for those vaccines. The pharmaceutical industry has already made significant commitments in this area as well. The companies involved in the agreement are committed to using donations for growing profits and using tiered pricing to make their products as affordable as possible. So another element here is that we need public funding to pay for these vaccines for all countries, and this is where the ACT Accelerator comes in. It's supported by Gavi and The Global Fund. Both organizations have spent two decades becoming experts in how to buy and deliver vaccines, diagnostics, and drugs to developing countries. The United Kingdom has donated enough money for the accelerator to purchase hundreds of millions of vaccine doses for poor countries. I want to thank Prime Minister Johnson and the Foreign Secretary for this amazing leadership commitment, and I want to encourage other countries to do the same. Finally, even when we have the manufacturing capacity and funding lined up, we'll need to strengthen health systems to achieve the broad coverage to deliver the vaccine and monitor for outbreaks. In doing this, we can take the lessons we've learned from the ongoing effort to eradicate polio. With the right diagnostics, health workers can also sound the alarm if a future disease jumps from bats or birds or any animal to humans. In other words, we can also be building the system that will help reduce the damage of the next pandemic. I'm confident that the world will build a plan to eliminate COVID-19, saving millions of lives and getting on a path to global recovery.
